|
US1724052A
(en)
|
1928-06-13 |
1929-08-13 |
Luther S Swearengin |
Fire-door construction
|
|
US5034506A
(en)
|
1985-03-15 |
1991-07-23 |
Anti-Gene Development Group |
Uncharged morpholino-based polymers having achiral intersubunit linkages
|
|
US5283058A
(en)
|
1990-08-30 |
1994-02-01 |
The General Hospital Corporation |
Methods for inhibiting rejection of transplanted tissue
|
|
JPH06502577A
(ja)
|
1991-07-30 |
1994-03-24 |
バクスター、インターナショナル、インコーポレイテッド |
有孔埋め込み物
|
|
US7101543B2
(en)
|
2000-03-31 |
2006-09-05 |
Novarx |
Genetically modified cells expressing a TGFβ inhibitor, the cells being lung cancer cells
|
|
AU2001255575B2
(en)
|
2000-04-28 |
2006-08-31 |
The Trustees Of The University Of Pennsylvania |
Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids
|
|
US20060222633A1
(en)
|
2000-05-11 |
2006-10-05 |
Yale University |
Prevention, decrease, and/or treatment of immunoreactivity by depleting and/or inactivating antigen presenting cells in the host
|
|
US6635750B1
(en)
|
2000-07-20 |
2003-10-21 |
Millennium Pharmaceuticals, Inc. |
B7-H2 nucleic acids, members of the B7 family
|
|
US7432104B2
(en)
|
2001-08-06 |
2008-10-07 |
Bresgen Inc. |
Methods for the culture of human embryonic stem cells on human feeder cells
|
|
JP4819697B2
(ja)
|
2003-12-23 |
2011-11-24 |
ヴィアサイト，インコーポレイテッド |
胚体内胚葉
|
|
US8586357B2
(en)
|
2003-12-23 |
2013-11-19 |
Viacyte, Inc. |
Markers of definitive endoderm
|
|
US7541185B2
(en)
|
2003-12-23 |
2009-06-02 |
Cythera, Inc. |
Methods for identifying factors for differentiating definitive endoderm
|
|
US20050266554A1
(en)
|
2004-04-27 |
2005-12-01 |
D Amour Kevin A |
PDX1 expressing endoderm
|
|
US7985585B2
(en)
|
2004-07-09 |
2011-07-26 |
Viacyte, Inc. |
Preprimitive streak and mesendoderm cells
|
|
JP5102030B2
(ja)
|
2004-08-13 |
2012-12-19 |
ユニバーシティ・オブ・ジョージア・リサーチ・ファウンデイション・インコーポレイテッド |
ヒト胚性幹細胞における自己再生および分化のための組成物および方法
|
|
US8999944B2
(en)
|
2005-01-20 |
2015-04-07 |
University Of Rochester |
Thioredoxin interacting protein (TXNIP) as regulator of vascular function
|
|
EP3584311A1
(en)
|
2005-10-27 |
2019-12-25 |
Viacyte, Inc. |
Pdx-1 expressing dorsal and ventral foregut endoderm
|
|
SG10201405107YA
(en)
|
2006-02-23 |
2014-10-30 |
Viacyte Inc |
Compositions and methods useful for culturing differentiable cells
|
|
DK2650359T3
(da)
|
2006-03-02 |
2022-06-13 |
Viacyte Inc |
Endokrine prekursorceller, pancreatiske hormon-udtrykkende celler og fremstillingsfremgangsmåder
|
|
US7695965B2
(en)
|
2006-03-02 |
2010-04-13 |
Cythera, Inc. |
Methods of producing pancreatic hormones
|
|
WO2007139929A2
(en)
|
2006-05-25 |
2007-12-06 |
The Burnham Institute For Medical Research |
Methods for culture and production of single cell populations of human embryonic stem cells
|
|
US9096832B2
(en)
|
2007-07-31 |
2015-08-04 |
Lifescan, Inc. |
Differentiation of human embryonic stem cells
|
|
US7695963B2
(en)
|
2007-09-24 |
2010-04-13 |
Cythera, Inc. |
Methods for increasing definitive endoderm production
|
|
US8623650B2
(en)
|
2007-10-19 |
2014-01-07 |
Viacyte, Inc. |
Methods and compositions for feeder-free pluripotent stem cell media containing human serum
|
|
ATE523585T1
(de)
|
2007-11-27 |
2011-09-15 |
Lifescan Inc |
Differenzierung menschlicher embryonaler stammzellen
|
|
US8338170B2
(en)
|
2008-04-21 |
2012-12-25 |
Viacyte, Inc. |
Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells
|
|
US7939322B2
(en)
|
2008-04-24 |
2011-05-10 |
Centocor Ortho Biotech Inc. |
Cells expressing pluripotency markers and expressing markers characteristic of the definitive endoderm
|
|
US20120058105A1
(en)
|
2008-06-27 |
2012-03-08 |
Martin Kean Chong Ng |
Method of treatment of vascular complications
|
|
MX2011004563A
(es)
|
2008-10-31 |
2011-06-01 |
Centocor Ortho Biotech Inc |
Diferenciacion de celulas madre embrionarias humanas al linaje endocrino pancreatico.
|
|
CN102272291B
(zh)
|
2008-10-31 |
2018-01-16 |
詹森生物科技公司 |
人胚胎干细胞向胰腺内分泌谱系的分化
|
|
US8008075B2
(en)
|
2008-11-04 |
2011-08-30 |
Viacyte, Inc. |
Stem cell aggregate suspension compositions and methods of differentiation thereof
|
|
US8895300B2
(en)
|
2008-11-04 |
2014-11-25 |
Viacyte, Inc. |
Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof
|
|
JP2012508584A
(ja)
|
2008-11-14 |
2012-04-12 |
ヴィアサイト，インコーポレイテッド |
ヒト多能性幹細胞由来膵臓細胞のカプセル化
|
|
US20100272710A1
(en)
|
2009-03-26 |
2010-10-28 |
Abdelhadi Rebbaa |
Compositions and methods for treating and preventing aging-associated diseases
|
|
US9109245B2
(en)
|
2009-04-22 |
2015-08-18 |
Viacyte, Inc. |
Cell compositions derived from dedifferentiated reprogrammed cells
|
|
ES2849181T3
(es)
|
2009-04-22 |
2021-08-16 |
Viacyte Inc |
Composiciones celulares derivadas de células reprogramadas desdiferenciadas
|
|
CN107603943B
(zh)
|
2009-04-27 |
2019-10-11 |
威盛细胞有限公司 |
支持多能细胞生长的小分子和其方法
|
|
ES2693088T3
(es)
|
2009-07-20 |
2018-12-07 |
Janssen Biotech, Inc. |
Diferenciación de células madre embriónicas humanas
|
|
AU2010276402B2
(en)
|
2009-07-20 |
2014-07-03 |
Janssen Biotech, Inc. |
Differentiation of human embryonic stem cells
|
|
MX339669B
(es)
|
2009-12-23 |
2016-06-02 |
Janssen Biotech Inc |
Diferenciacion de celulas madres embrionarias humanas.
|
|
AU2010333839C1
(en)
|
2009-12-23 |
2016-07-21 |
Janssen Biotech Inc. |
Differentiation of human embryonic stem cells
|
|
WO2012030539A2
(en)
|
2010-08-31 |
2012-03-08 |
Janssen Biotech, Inc. |
Differentiation of human embryonic stem cells
|
|
WO2012030540A2
(en)
|
2010-08-31 |
2012-03-08 |
Janssen Biotech, Inc. |
Differentiation of pluripotent stem cells
|
|
US9365830B2
(en)
|
2010-12-08 |
2016-06-14 |
Viacyte, Inc. |
Agents and methods for inhibiting human pluripotent stem cell growth
|
|
JP2014513948A
(ja)
|
2011-04-20 |
2014-06-19 |
ザ ユニバーシティ オブ ワシントン スルー イッツ センター フォー コマーシャライゼーション |
β２ミクログロブリン欠損細胞
|
|
USD728095S1
(en)
|
2011-12-12 |
2015-04-28 |
Viacyte, Inc. |
Cell encapsulation device
|
|
USD726306S1
(en)
|
2011-12-12 |
2015-04-07 |
Viacyte, Inc. |
Cell encapsulation device
|
|
USD726307S1
(en)
|
2011-12-12 |
2015-04-07 |
Viacyte Inc. |
Cell encapsulation device
|
|
JP2015501844A
(ja)
|
2011-12-16 |
2015-01-19 |
モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
修飾ヌクレオシド、ヌクレオチドおよび核酸組成物
|
|
US9388386B2
(en)
|
2011-12-22 |
2016-07-12 |
Janssen Biotech, Inc. |
Differentiation of human embryonic stem cells into single hormonal insulin positive cells
|
|
EP2657340B1
(en)
|
2012-04-25 |
2016-11-16 |
Deutsches Krebsforschungszentrum |
Inhibitors of thioredoxin-interacting protein (TXNIP) for therapy
|
|
AR090970A1
(es)
|
2012-05-07 |
2014-12-17 |
Janssen Biotech Inc |
Diferenciacion de celulas madre humanas embrionarias en endodermo pancreatico
|
|
LT3401400T
(lt)
|
2012-05-25 |
2019-06-10 |
The Regents Of The University Of California |
Būdai ir kompozicijos, skirtos rnr molekulės nukreipiamai tikslinės dnr modifikacijai ir rnr molekulės nukreipiamam transkripcijos moduliavimui
|
|
USD734847S1
(en)
|
2012-05-31 |
2015-07-21 |
Viacyte, Inc. |
Cell encapsulation device
|
|
WO2013184888A1
(en)
|
2012-06-08 |
2013-12-12 |
Janssen Biotech, Inc. |
Differentiation of human embryonic stem cells into pancreatic endocrine cells
|
|
KR20150030709A
(ko)
|
2012-06-14 |
2015-03-20 |
얀센 바이오테크 인코포레이티드 |
인간 배아 줄기 세포의 췌장 내분비 세포로의 분화
|
|
JP2016504026A
(ja)
|
2012-12-12 |
2016-02-12 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
配列操作のための系、方法および最適化ガイド組成物のエンジニアリング
|
|
US10370644B2
(en)
|
2012-12-31 |
2019-08-06 |
Janssen Biotech, Inc. |
Method for making human pluripotent suspension cultures and cells derived therefrom
|
|
WO2014105543A1
(en)
|
2012-12-31 |
2014-07-03 |
Janssen Biotech, Inc. |
Culturing of human embryonic stem cells at the air-liquid interface for differentiation into pancreatic endocrine cells
|
|
RU2687379C2
(ru)
|
2012-12-31 |
2019-05-13 |
Янссен Байотек, Инк. |
Суспендирование и кластеризация плюрипотентных клеток человека с целью их дифференцировки в панкреатические эндокринные клетки
|
|
RU2684215C2
(ru)
|
2012-12-31 |
2019-04-04 |
Янссен Байотек, Инк. |
Способ получения панкреатических эндокринных клеток (варианты) и способ увеличения выхода бета-клеток
|
|
ES2681602T3
(es)
|
2013-03-07 |
2018-09-14 |
Viacyte, Inc. |
Ensamblaje de dispositivo de encapsulación celular tridimensional de gran capacidad
|
|
USD720469S1
(en)
|
2013-03-07 |
2014-12-30 |
Viacyte, Inc. |
Cell encapsulation device
|
|
US9101597B2
(en)
|
2013-03-14 |
2015-08-11 |
The Administration Of The Tulane Educational Fund |
Immunoprotective primary mesenchymal stem cells and methods
|
|
US8859286B2
(en)
|
2013-03-14 |
2014-10-14 |
Viacyte, Inc. |
In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells
|
|
CA2913854A1
(en)
|
2013-06-03 |
2014-12-11 |
Theravectys |
Lentiviral vectors containing an mhc class i, mhc class ii, or beta-2 microglobulin upstream promoter sequence
|
|
KR102580225B1
(ko)
|
2013-06-11 |
2023-09-20 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
SC-β 세포 및 조성물 그리고 그 생성 방법
|
|
KR20140144964A
(ko)
|
2013-06-12 |
2014-12-22 |
한국생명공학연구원 |
티오레독신-결합 단백질을 유효성분으로 포함하는 약학적 조성물 및 이의 용도
|
|
CN105793425B
(zh)
|
2013-06-17 |
2021-10-26 |
布罗德研究所有限公司 |
使用病毒组分靶向障碍和疾病的crispr-cas系统和组合物的递送、用途和治疗应用
|
|
KR20180128529A
(ko)
|
2013-11-01 |
2018-12-03 |
얀센 바이오테크 인코포레이티드 |
췌장 내분비 세포로의 분화를 위한 인간 만능 줄기세포의 현탁 및 클러스터링
|
|
USD714956S1
(en)
|
2014-03-07 |
2014-10-07 |
Viacyte, Inc. |
3-dimensional large capacity cell encapsulation device
|
|
USD718470S1
(en)
|
2014-03-07 |
2014-11-25 |
Viacyte, Inc. |
3-dimensional large capacity cell encapsulation device
|
|
USD718466S1
(en)
|
2014-03-07 |
2014-11-25 |
Viacyte, Inc. |
3-Dimensional large capacity cell encapsulation device
|
|
USD718468S1
(en)
|
2014-03-07 |
2014-11-25 |
Viacyte, Inc. |
3-dimensional large capacity cell encapsulation device
|
|
USD718471S1
(en)
|
2014-03-07 |
2014-11-25 |
Viacyte, Inc. |
3-dimensional large capacity cell encapsulation device
|
|
USD718467S1
(en)
|
2014-03-07 |
2014-11-25 |
Viacyte, Inc. |
3-dimensional large capacity cell encapsulation device
|
|
USD718469S1
(en)
|
2014-03-07 |
2014-11-25 |
Viacyte, Inc. |
3-dimensional large capacity cell encapsulation device
|
|
USD718472S1
(en)
|
2014-03-07 |
2014-11-25 |
Viacyte, Inc. |
3-dimensional large capacity cell encapsulation device
|
|
MX373460B
(es)
|
2014-03-11 |
2020-04-07 |
Cellectis |
Metodo para generar celulas t compatibles para el trasplante alogenico.
|
|
US20170274048A1
(en)
*
|
2014-03-28 |
2017-09-28 |
Buck Institute For Research On Aging |
Methods and compositions for modulating the imune system
|
|
USD760399S1
(en)
|
2014-04-16 |
2016-06-28 |
Viacyte, Inc. |
Case for an encapsulation device
|
|
USD761424S1
(en)
|
2014-04-16 |
2016-07-12 |
Viacyte, Inc. |
Deployment tool for an encapsulation device
|
|
USD734166S1
(en)
|
2014-04-16 |
2015-07-14 |
Viacyte, Inc. |
Fill pouch assembly for encapsulation device
|
|
USD761423S1
(en)
|
2014-04-16 |
2016-07-12 |
Viacyte, Inc. |
Sizing tool for an encapsulation device
|
|
JP6588969B2
(ja)
|
2014-05-16 |
2019-10-09 |
ヤンセン バイオテツク，インコーポレーテツド |
膵内分泌細胞内のｍａｆａ発現を強化するための小分子の使用
|
|
EP3215623A4
(en)
|
2014-11-06 |
2018-09-26 |
President and Fellows of Harvard College |
Cells lacking b2m surface expression and methods for allogeneic administration of such cells
|
|
EP3234109A4
(en)
|
2014-12-19 |
2018-06-27 |
Janssen Biotech, Inc. |
Suspension culturing of pluripotent stem cells
|
|
CA2988854A1
(en)
|
2015-05-08 |
2016-11-17 |
President And Fellows Of Harvard College |
Universal donor stem cells and related methods
|
|
GB2557123B
(en)
|
2015-07-31 |
2021-11-03 |
Univ Minnesota |
Modified cells and methods of therapy
|
|
CN108368520B
(zh)
*
|
2015-11-04 |
2023-01-17 |
菲特治疗公司 |
多能细胞的基因组工程改造
|
|
EP4691479A3
(en)
|
2016-06-21 |
2026-04-15 |
Janssen Biotech, Inc. |
Generation of human pluripotent stem cell derived functional beta cells showing a glucose-dependent mitochondrial respiration and two-phase insulin secretion response
|
|
WO2018035387A1
(en)
|
2016-08-17 |
2018-02-22 |
The Broad Institute, Inc. |
Novel crispr enzymes and systems
|
|
US9982267B2
(en)
|
2016-10-12 |
2018-05-29 |
Feldan Bio Inc. |
Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same
|
|
JP7088564B2
(ja)
|
2016-11-10 |
2022-06-21 |
ヴィアサイト，インコーポレイテッド |
細胞送達装置におけるｐｄｘ１膵臓内胚葉細胞及びその方法
|
|
KR20190103373A
(ko)
|
2017-01-13 |
2019-09-04 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
면역조작된 만능 세포
|
|
US11771703B2
(en)
|
2017-03-17 |
2023-10-03 |
The Johns Hopkins University |
Targeted epigenetic therapy against distal regulatory element of TGFβ2 expression
|
|
WO2018227286A1
(en)
|
2017-06-12 |
2018-12-20 |
Sinai Health System |
Allograft tolerance without the need for systemic immune suppression
|
|
US10391156B2
(en)
|
2017-07-12 |
2019-08-27 |
Viacyte, Inc. |
University donor cells and related methods
|
|
EP3684919A1
(en)
|
2017-10-19 |
2020-07-29 |
Cellectis |
Targeted gene integration of nk inhibitors genes for improved immune cells therapy
|
|
CN107723275B
(zh)
|
2017-10-20 |
2020-09-04 |
重庆精准生物技术有限公司 |
通用型car-t细胞及其制备方法和应用
|
|
MX2020005235A
(es)
|
2017-11-16 |
2020-08-24 |
Mogam Inst Biomedical Res |
Celula humana transformada y uso de la misma.
|
|
BR112020010597A2
(pt)
|
2017-12-08 |
2020-10-27 |
Fate Therapeutics, Inc. |
imunoterapias com o uso de células efetoras derivadas de ipsc intensificadas
|
|
US20190223416A1
(en)
|
2018-01-23 |
2019-07-25 |
Cotyledon, LLC |
Canine genome editing
|
|
EP3754018A4
(en)
|
2018-02-16 |
2021-11-24 |
Kyoto University |
METHOD OF MANUFACTURING A WEAK ANTIGENT CELL
|
|
US10724052B2
(en)
|
2018-09-07 |
2020-07-28 |
Crispr Therapeutics Ag |
Universal donor cells
|
|
EP3886759A1
(en)
|
2018-11-26 |
2021-10-06 |
Massachusetts Institute of Technology |
Compositions and methods for immune tolerance
|
|
US12622932B2
(en)
|
2018-12-13 |
2026-05-12 |
Sinai Health System |
Immunomodulatory cells and uses thereof
|
|
WO2020206055A1
(en)
|
2019-04-02 |
2020-10-08 |
Yale University |
Methods of treatment of diseases and disorders associated with increased tet level, increased h19 level, increased level of tgf signaling, or any combination thereof
|
|
CA3138597A1
(en)
*
|
2019-05-10 |
2020-11-19 |
The Regents Of The University Of California |
Modified pluripotent cells
|
|
WO2020228039A1
(en)
*
|
2019-05-16 |
2020-11-19 |
Egenesis, Inc. |
Cells, tissues, organs, and/or animals having one or more modified genes for enhanced xenograft survival and/or tolerance
|
|
CN110373389A
(zh)
*
|
2019-06-10 |
2019-10-25 |
云南农业大学 |
一种适合胰岛细胞及皮肤等组织异种移植供体猪的构建方法
|
|
US11118195B2
(en)
|
2019-09-05 |
2021-09-14 |
Crispr Therapeutics Ag |
Universal donor cells
|
|
AU2020340622A1
(en)
|
2019-09-05 |
2022-03-03 |
Crispr Therapeutics Ag |
Universal donor cells
|
|
KR20230146007A
(ko)
|
2020-12-31 |
2023-10-18 |
크리스퍼 테라퓨틱스 아게 |
범용 공여자 세포
|